Corcept Therapeutics Inc (CORT.OQ)
18.17USD
19 Apr 2018
$0.25 (+1.40%)
$17.92
$17.82
$18.28
$17.46
249,046
658,427
$25.92
$8.90
About
Overall
| Beta: | 2.07 |
| Market Cap(Mil.): | $2,309.91 |
| Shares Outstanding(Mil.): | 113.40 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CORT.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 101.94 | 30.95 | 32.74 |
| EPS (TTM): | 0.20 | -- | -- |
| ROI: | 50.69 | 14.84 | 14.38 |
| ROE: | 52.76 | 16.34 | 16.07 |
BRIEF-Corcept Therapeutics Files Lawsuit Against Teva Pharmaceuticals For Infringement Of Korlym Patents
* CORCEPT THERAPEUTICS FILES LAWSUIT AGAINST TEVA PHARMACEUTICALS FOR INFRINGEMENT OF KORLYM PATENTS
BRIEF-Corcept Therapeutics Q4 GAAP Earnings Per Share $0.77
* CORCEPT THERAPEUTICS ANNOUNCES 2017 FINANCIAL RESULTS AND POSITIVE INTERIM RESULTS OF RELACORILANT PHASE 2 TRIAL
BRIEF-Corcept Therapeutics Q4 GAAP Earnings Per Share $0.77
* CORCEPT THERAPEUTICS ANNOUNCES 2017 FINANCIAL RESULTS AND POSITIVE INTERIM RESULTS OF RELACORILANT PHASE 2 TRIAL
BRIEF-Corcept Therapeutics Receives Letter on saying Teva Pharmaceuticals USA Submitted An Abbreviated New Drug Application
* CORCEPT THERAPEUTICS - RECEIVED PARAGRAPH IV NOTICE LETTER ADVISING THAT TEVA PHARMACEUTICALS USA SUBMITTED AN ABBREVIATED NEW DRUG APPLICATION TO FDA
BRIEF-Corcept Therapeutics, Dohmen Entered Into Settlement Agreement And Mutual Release Of Any And All Claims That May Have Existed Between Parties
* CORCEPT THERAPEUTICS - CO, DOHMEN ENTERED INTO SETTLEMENT AGREEMENT AND MUTUAL RELEASE OF ANY AND ALL CLAIMS THAT MAY HAVE EXISTED BETWEEN PARTIES
BRIEF-Corcept Therapeutics posts Q3 earnings per share $0.11
* Corcept Therapeutics announces third quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update
Competitors
| Price | Chg | |
|---|---|---|
| Novartis AG (NOVN.S) | CHF77.28 | -- |
| Pfizer Inc. (PFE.N) | $36.53 | +0.04 |
| Merck & Co., Inc. (MRK.N) | $58.64 | -0.28 |
| GlaxoSmithKline plc (GSK.L) | 1,407.40 | -- |
| AstraZeneca plc (AZN.L) | 4,955.50 | -- |
| Eli Lilly And Co (LLY.N) | $79.75 | +0.03 |
| Bristol-Myers Squibb Co (BMY.N) | $51.61 | -0.69 |
| Bristol-Myers Squibb Co (BMYMP.PK) | $1,306.55 | -- |
Estimates